320 related articles for article (PubMed ID: 24416395)
1. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
Gumulec J; Raudenska M; Adam V; Kizek R; Masarik M
PLoS One; 2014; 9(1):e85346. PubMed ID: 24416395
[TBL] [Abstract][Full Text] [Related]
2. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma.
Dutsch-Wicherek M; Popiela TJ; Klimek M; Rudnicka-Sosin L; Wicherek L; Oudinet JP; Skladzien J; Tomaszewska R
Neuro Endocrinol Lett; 2005 Oct; 26(5):567-74. PubMed ID: 16264399
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
[TBL] [Abstract][Full Text] [Related]
7. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
8. Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma.
Park Y; Yu E
J Gastroenterol Hepatol; 2013 Sep; 28(9):1565-72. PubMed ID: 23662831
[TBL] [Abstract][Full Text] [Related]
9. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
[TBL] [Abstract][Full Text] [Related]
11. Glutathione levels in human tumors.
Gamcsik MP; Kasibhatla MS; Teeter SD; Colvin OM
Biomarkers; 2012 Dec; 17(8):671-91. PubMed ID: 22900535
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis.
Zhao L; Li J; Liu M; Zhou H; Zou H; Wei Y; Sun K; Li G; Li S; Pang L
Future Oncol; 2017 Dec; 13(28):2555-2570. PubMed ID: 29168665
[TBL] [Abstract][Full Text] [Related]
13. HER3 overexpression and survival in solid tumors: a meta-analysis.
Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E
J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis.
Hengstler JG; Pilch H; Schmidt M; Dahlenburg H; Sagemüller J; Schiffer I; Oesch F; Knapstein PG; Kaina B; Tanner B
Int J Cancer; 2001 Mar; 95(2):121-7. PubMed ID: 11241323
[TBL] [Abstract][Full Text] [Related]
15. Smoking and Drinking Adjusted Association between Head and Neck Cancers and Oral Health Status Related to Periodontitis: a Meta-Analysis.
Vu H; Shin YJ; Kong MS; Kim HD
J Korean Med Sci; 2021 Apr; 36(15):e98. PubMed ID: 33876587
[TBL] [Abstract][Full Text] [Related]
16. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
Kumarasamy C; Devi A; Jayaraj R
Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
[TBL] [Abstract][Full Text] [Related]
18. Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemical study based on the expression of metallothionein.
Hinkel A; Schmidtchen S; Palisaar RJ; Noldus J; Pannek J
J Toxicol Environ Health A; 2008; 71(13-14):954-9. PubMed ID: 18569601
[TBL] [Abstract][Full Text] [Related]
19. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein as a prognostic biomarker in breast cancer.
Bay BH; Jin R; Huang J; Tan PH
Exp Biol Med (Maywood); 2006 Oct; 231(9):1516-21. PubMed ID: 17018874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]